Ameliorated effects of a lipopeptide surfactin on insulin resistance in vitro and in vivo

Surfactin, produced by Bacillus amyloliquefaciens fmb50, was used to treat insulin‐resistant (IR) hepatocyte. It was found that surfactin increased glucose consumption in insulin‐resistant HepG2 (IR‐HepG2) cells and ameliorated IR by increasing glucose transporter 4 (GLUT4) protein expression and AM...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Xiaoyu, Zhao, Hongyuan, Meng, Fanqiang, Zhou, Libang, Pang, Xinyi, Lu, Zhaoxin, Lu, Yingjian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9281957/
https://www.ncbi.nlm.nih.gov/pubmed/35844917
http://dx.doi.org/10.1002/fsn3.2852

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9281957/
https://www.ncbi.nlm.nih.gov/pubmed/35844917
http://dx.doi.org/10.1002/fsn3.2852

Ejemplares similares